Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
The Geriatric Scoring System (GSS) in meningioma patients - Validation
Or Cohen-Inbar
, Gil E. Sviri
, Jean F. Soustiel
, Menashe Zaaroor
Technion-Israel Institute of Technology
Neurosurgical Department
Research output
:
Contribution to journal
›
Article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Geriatric Scoring System (GSS) in meningioma patients - Validation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Scoring System
100%
Geriatrics
100%
Meningioma
100%
Risk Stratification
28%
Chronic Illness
14%
Outcome Prediction
14%
Health Status
14%
Elderly Patients
14%
Favorable Outcome
14%
Length of Hospital Stay
14%
Physical State
14%
Surgical Intervention
14%
Primary Brain Tumor
14%
After Surgery
14%
Experience-based
14%
Medical Center
14%
Glasgow Coma Scale
14%
Functional State
14%
Prognostic Indicator
14%
Karnofsky Performance Status
14%
Evidence-based Decision Making
14%
Presenting Symptoms
14%
Barthel Index
14%
Intracranial Meningioma
14%
Predictive Decision
14%
Radiological Features
14%
Over 65
14%
Common Experience
14%
Neurointensive Care Unit
14%
Medicine and Dentistry
Scoring System
100%
Geriatrics
100%
Meningioma
100%
Risk Stratification
28%
Decision Making
14%
Symptom
14%
Recurrent Disease
14%
Chronic Disease
14%
Prognosis
14%
Brain Tumor
14%
Elderly Patient
14%
Intensive Care Unit
14%
Glasgow Coma Scale
14%
Barthel Index
14%
Karnofsky Performance Status
14%
Surgery
14%
Pharmacology, Toxicology and Pharmaceutical Science
Meningioma
100%
Recurrent Disease
25%
Prognosis
25%
Chronic Disease
25%
Symptom
25%
Glasgow Coma Scale
25%
Barthel Index
25%
Brain Tumor
25%
Neuroscience
Meningioma
100%
Decision-Making
25%
Glasgow Coma Scale
25%
Brain Tumor
25%